References
- Kim WO. Institutional Review Board (IRB) and ethical issues in clinical research historical views on human subject research. Korean J Anesthesiol. 2012;62(1):3–12.
- Savulescu J, Chalmers I, Blunt J. Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability. BMJ. 1996;313(7069):1390–1393.
- Weijer C, Shapiro S, Fuks A, et al. Monitoring clinical research: an obligation unfulfilled. CMAJ. 1995;152(12):1973–1980.
- Shafiq N, Kumari S, Kumar V, et al. On-site monitoring of clinical trials by an ethics committee in India: a road less travelled. Res Ethics. 2021;17(1):45–54.
- Rice TW. The historical, ethical, and legal background of human-subjects research. Respir Care. 2008;53(10):1325–1329.
- Cox S, Solbakk JH, Bernabe RDLC. The role of research ethics committees after the approval of clinical trial protocols in the EU and the USA: a descriptive content analysis of international and regional normative documents. Curr Med Res Opin. 2021;37(6):1061–1069.
- Cox S, Solbakk JH, Bernabe RDLC. Research ethics committees and post-approval activities: a qualitative study on the perspectives of european research ethics committee representatives. Curr Med Res Opin. 2022;38(11):1897–1907.
- Brown B, Kinsler J, Folayan MO, et al. Post-approval monitoring and oversight of U.S.-initiated human subjects research in resource-constrained countries. J Bioeth Inq. 2014;11(2):119–123.
- Young M. In new common rule era, there is role for post-approval monitoring. Relias Media. 2019. [cited 2021 Sep 11]. https://www.reliasmedia.com/articles/145106-in-new-common-rule-era-there-is-role-for-post-approval-monitoring.
- Young M. Sample models of post-approval monitoring programs. Relias Media. 2019. [cited 2021 Sep 11]. https://www.reliasmedia.com/articles/145107-sample-models-of-post-approval-monitoring-programs.
- AAHCI. Academic health centers. Association of Academic Health Centers. 2022. [cited 2022 Sep 15]. https://www.aahcdc.org/About/Academic-Health-Centers.
- Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
- Braun V, Clarke V. One size fits all? What counts as quality practice in (reflexive) thematic analysis? Qual Res Psychol. 2020;18(3):328–352.
- Boateng O, Ndebele P, Mwesiga-Kayongo D. Research ethics in Africa: a resource for research ethics committees. Stellenbosch: SUN MeDIA; 2014.
- Berry J, Piwncess T, Hospital R, et al. Local research ethics committees can audit ethical standards in research. J Med Ethics. 1997;23(6):379–381.
- McNeill PM, Berglund CA, Webster IW. Do Australian researchers accept committee review and conduct ethical research. Soc Sci Med. 1992;35(3):317–322.
- Pickworth E. Should local research ethics committees monitor research they have approved. J Med Ethics. 2000;26(5):330–333. ?
- OHRP. Federalwide assurance instructions. HHS.gov. 2017. [cited 2021 Feb 09]. https://www.hhs.gov/ohrp/register-irbs-and-obtain-fwas/forms/fwa-instructions/index.html.
- Steinbrook R. Improving protection for research subjects. N Engl J Med. 2002;346(18):1425–1430.
- Rinde M. The death of Jesse Gelsinger, 20 years later [Online]. Science History Institute. Distillations. 2019. [cited 2022 Mar 18]. https://www.sciencehistory.org/distillations/the-death-of-jesse-gelsinger-20-years-later.
- Stephenson J. Gene therapy trials oversight. JAMA. 2000;283(15):1950–1950.
- Savulescu J, Spriggs M. The hexamethonium asthma study and the death of a normal volunteer in research. J Med Ethics. 2002;28(1):3–4.
- Babb S. Regulating human research: IRBs from peer review to compliance bureaucracy. Stanford: Stanford University Press; 2020.
- FDA. IRB continuing review after clinical investigation. Rockville (MD): US Food and Drug Administration; 2012. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/irb-continuing-review-after-clinical-investigation-approval.
- FDA. 21 CFR 56. 2019. https://www.ecfr.gov/cgi-bin/text-idx?SID=7681dfad0d169cfef7a609461bcf00b4&mc=true&node=pt21.1.56&rgn=div5.
- Bernabe R, van Thiel G, Breekveldt N, et al. Drug regulators and ethics: which GCP issues are also ethical issues. Drug Discov Today. 2016;21(2): 217–224.
- Bernabe R, van Thiel G, Breekveldt N, et al. Ethics in clinical trial regulation: ethically relevant issues from EMA inspection reports. Curr Med Res Opin. 2019;35(4):637–645.
- Seife C. Research misconduct identified by the US food and drug administration: out of sight, out of mind, out of the peer-reviewed literature. JAMA Intern Med. 2015;175(4):567–577.
- Klitzman R. The ethics police?: ‘IRBs’ views concerning their power. PLoS One. 2011;6(12):e28773.